Combination of targeted therapy and immunotherapy in melanoma Christian U. BlankAnna I. HooijkaasTon N. Schumacher Review 17 August 2011 Pages: 1359 - 1371
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy Anna Maria BerghellaPatrizia PellegriniIda Contasta Perspectives Open access 08 July 2011 Pages: 1373 - 1381
Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma Laura AlanizManglio RizzoGuillermo Mazzolini Original article 03 June 2011 Pages: 1383 - 1395
Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers Goki ShindoTakayoshi EndoShigenori Goto Original article 03 June 2011 Pages: 1397 - 1403
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity Sebastian F. M. HäuslerItsaso Montalbán del BarrioJörg Wischhusen Original article 03 June 2011 Pages: 1405 - 1418
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13 Rachel F. GabitassNicola E. AnnelsGary W. Middleton Original article Open access 05 June 2011 Pages: 1419 - 1430
Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release Mladen KorbelikWei ZhangSoroush Merchant Original article 05 June 2011 Pages: 1431 - 1437
An ADP ribosylation factor-GTPase activating protein negatively regulates the production of proinflammatory mediators in response to lipopolysaccharide Abedul HaqueAbu Shadat Mohammod NomanTakashi Yokochi Original article 05 June 2011 Pages: 1439 - 1446
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma Joshua M. LangMahazarin R. KaikobadMiroslav Malkovsky Original article 07 June 2011 Pages: 1447 - 1460
Myxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumors Diana L. ThomasRosalinda DotyEdward J. Roy Original article 09 June 2011 Pages: 1461 - 1472
Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity Manjunatha Ankathatti MunegowdaYulin DengJim Xiang Original article 10 June 2011 Pages: 1473 - 1484
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients Fabio MorandiMaria Valeria CorriasVito Pistoia Original article 10 June 2011 Pages: 1485 - 1495
Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer Runbo ZhongJiajun TengHua Zhong Original Article 17 June 2011 Pages: 1497 - 1502
The n3-polyunsaturated fatty acid docosahexaenoic acid induces immunogenic cell death in human cancer cell lines via pre-apoptotic calreticulin exposure Romina MolinariDonatella D’EliseoNicolò Merendino Short communication 22 July 2011 Pages: 1503 - 1507